stock and time

November 4, 2024

Myriad Genetics, Inc. Lawsuit Submission Form

On October 31, 2024, it was revealed that UnitedHealth Group (“UnitedHealth”) would no longer cover GeneSight, Myriad’s genetic test to help determine which mental health medications are likely to work with an individual patient, beginning January 1, 2025. Specifically, market a...
Learn More

On October 31, 2024, it was revealed that UnitedHealth Group (“UnitedHealth”) would no longer cover GeneSight, Myriad’s genetic test to help determine which mental health medications are likely to work with an individual patient, beginning January 1, 2025. Specifically, market analysts reported that a document from UnitedHealth stated that the coverage is ending as tests for behavioral health, which includes GeneSight, are “unproven” and “not medically necessary.”

Following this news, Myriad’s stock price fell over 18% on November 1, 2024.

Active Cases

Ticker Symbol Company Name Deadline
AGEN Agenus Inc. November 05, 2024 View
NFE New Fortress Energy Inc. November 18, 2024 View
DPZ Domino's Pizza, Inc. November 19, 2024 View
MGX Metagenomi, Inc. November 25, 2024 View
BMBL Bumble Inc. November 25, 2024 View
LLAP Terran Orbital Corporation November 26, 2024 View
LLAP Terran Orbital Corporation November 26, 2024 View
FNA Paragon 28, Inc. November 29, 2024 View
ELAN Elanco Animal Health Incorporated December 06, 2024 View
IREN Iris Energy Limited December 06, 2024 View
AILE iLearningEngines, Inc. December 06, 2024 View
UPS United Parcel Service, Inc. December 09, 2024 View
EW Edwards Lifesciences Corporation December 13, 2024 View
MAPS WM Technology, Inc. December 16, 2024 View
MAPS WM Technology, Inc. December 16, 2024 View
MAPS WM Technology, Inc. December 16, 2024 View
AIXI Xiao-I Corporation December 16, 2024 View
TD The Toronto-Dominion Bank December 23, 2024 View